Top Highlights for December 2014: (Please click on read more to see details)
- Dr. Reddy’s Laboratories closes acquisition of Habitrol® Brand from Novartis
- Cipla bags US $183 million anti-Aids drug contract from South Africa Read more
- CCI approves Ranbaxy acquisition by Sun Pharma
- Cipla sells stake in Chinese JV Jiangsu Cdymax for US $18.5 mn Read more
- Aurobindo Pharma completes US $132.5 million Natrol Acquisition Read more
- Glenmark in talks with multinationals to out-license US $1bn market potential molecule for pain management Read more
- German Bosch, India based Klenzaids create JV with Mumbai HQ to expand reach in liquid pharmaceuticals
- Emami partners with Germany’s Hevert-Arzneimittel Read more
- Torrent Pharma and Reliance Life Sciences ink exclusive licensing agreement for three biosimilars
- GVK BIO strengthens tie-up with CTC Life Science Japan
- Panacea Biotec India in international collaboration for development and supply of an immunosuppressant generic product in USA
- Indian vaccine major, Indian Immunologicals forays into the international market by forming a subsidiary in New Zealand
For more such news and updates on Global Life Science Business in India please join our Group on LinkedIn by the same name.
Aagami Updates: (Please click on hyperlink to view details)
- Aagami's latest Company Presentation and Case Studies are available on its company website.
- Aagami to participate in JP Morgan Healthcare and BioTech Showcase in Jan 2015